Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 217

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 6
Chunk 217
---
ee (whether vested or unvested)
will terminate on the date of such termination and the shares covered by such awards shall again be available for issuance under the 2016
Plan.

Transactions. In the
event of division or subdivision of our outstanding share capital, any distribution of bonus shares (share split), consolidation or combination
of our share capital (reverse share split), reclassification with respect to the shares or any similar recapitalization events, a merger,
consolidation, amalgamation or like transaction of our business with or into another corporation, a reorganization (which may include
a combination or exchange of shares, spin-off or other corporate divestiture or division), or other similar occurrences, the Administrator
shall have the authority to make, without the need for a consent of any holder of an award, such adjustments in order to adjust the number
and class of shares reserved and available for grants of awards, the number and class of shares covered by outstanding awards, the exercise
price per share covered by any award, the terms and conditions concerning vesting and exercisability and the term and duration of the
outstanding awards, and any other terms of the award that in the opinion of the Administrator should be adjusted. Any fractional shares
resulting from such adjustment shall be treated as determined by the Administrator, and in the absence of such determination shall be
rounded to the nearest whole share, and we shall have no obligation to make any cash or other payment with respect to such fractional
shares. No adjustment shall be made by reason of the distribution of subscription rights or rights offering to outstanding shares or other
issuance of shares by us, unless the Administrator determines otherwise.

In the event of a merger or
consolidation of our business, or a sale of all, or substantially all, of our shares or assets or a scheme of arrangement for the purpose
of effecting such merger, consolidation, sale or such other transaction having a similar effect on us (as described in the 2016 Plan),
or liquidation or dissolution of our business, or such other transaction or circumstances as determined by our board of directors (“ Merger/Sale”),
then without the consent of the grantee, the Administrator may, but is not required to, among other things, (i) cause any outstanding
award to be assumed or substituted by us, or by the successor corporation in such Merger/Sale, or (ii) regardless of whether or not awards
are assumed or substituted (a) provide the grantee